Redhill Biopharma Earnings Calls

Mar 31, 2026
Release date Apr 09, 2026
EPS estimate -$435.00
EPS actual -
Revenue estimate 22.703M
Revenue actual -
Dec 31, 2025
Release date Mar 30, 2026
EPS estimate -$435.00
EPS actual -
Revenue estimate 22.703M
Revenue actual -
Sep 30, 2025 (Upcoming)
Release date Aug 20, 2026
EPS estimate -$690.00
EPS actual -
Revenue estimate 4.378M
Revenue actual -
Expected change +/- 11.62%
Jun 30, 2025
Release date Sep 05, 2025
EPS estimate -
EPS actual -$1.15
Revenue estimate -
Revenue actual 2.039M

Last 4 Quarters for Redhill Biopharma

Below you can see how RDHL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Jun 30, 2025
Release date Sep 05, 2025
Price on release $1.43
EPS estimate -
EPS actual -$1.15
Date Price
Aug 29, 2025 $1.35
Sep 02, 2025 $1.30
Sep 03, 2025 $1.28
Sep 04, 2025 $1.23
Sep 05, 2025 $1.43
Sep 08, 2025 $1.44
Sep 09, 2025 $1.42
Sep 10, 2025 $1.51
Sep 11, 2025 $1.60
4 days before 6.19%
4 days after 11.61%
On release day 0.453%
Change in period 18.52%
Sep 30, 2025 (Upcoming)
Release date Aug 20, 2026
Price on release -
EPS estimate -$690.00
EPS actual -
Date Price
May 28, 2026 $1.00
May 29, 2026 $1.00
Jun 01, 2026 $1.00
Jun 02, 2026 $1.01
Jun 03, 2026 $1.00
Dec 31, 2025
Release date Mar 30, 2026
Price on release $0.745
EPS estimate -$435.00
EPS actual -
Date Price
Mar 24, 2026 $0.89
Mar 25, 2026 $0.89
Mar 26, 2026 $0.781
Mar 27, 2026 $0.750
Mar 30, 2026 $0.745
Mar 31, 2026 $0.745
Apr 01, 2026 $0.81
Apr 02, 2026 $0.799
Apr 06, 2026 $0.83
4 days before -16.32%
4 days after 11.33%
On release day 0.0671%
Change in period -6.83%
Mar 31, 2026
Release date Apr 09, 2026
Price on release $0.83
EPS estimate -$435.00
EPS actual -
Date Price
Apr 02, 2026 $0.799
Apr 06, 2026 $0.83
Apr 07, 2026 $0.80
Apr 08, 2026 $0.800
Apr 09, 2026 $0.83
Apr 10, 2026 $0.83
Apr 13, 2026 $0.81
Apr 14, 2026 $0.81
Apr 15, 2026 $0.81
4 days before 3.97%
4 days after -2.18%
On release day -0.722%
Change in period 1.70%

Redhill Biopharma Earnings History

Earnings Calendar

FAQ

When is the earnings report for RDHL?
Redhill Biopharma Ltd. (RDHL) has scheduled its earnings report for Aug 13, 2026 after the markets close.

What is the RDHL price-to-earnings (P/E) ratio?
RDHL P/E ratio as of Jun 03, 2026 (TTM) is -0.268.

What is the RDHL EPS forecast?
The forecasted EPS (Earnings Per Share) for Redhill Biopharma Ltd. (RDHL) for the first fiscal quarter 2026 is -$352.86.

What are Redhill Biopharma Ltd.'s retained earnings?
On its balance sheet, Redhill Biopharma Ltd. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT REDHILL BIOPHARMA LTD.
Redhill Biopharma
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development pr...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE